🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the efficacy of two doses of subling...
Status
Completed
Location
Multiple Locations
Start Date
2007-10
Trial ID
NCT00674700
The objective of this study is to determine the biologic activity of a Chen...
Status
Completed
Location
Hospital General de Elche
Start Date
2012-11
Trial ID
NCT01675349
Treatments Being Tested
Prospective, randomised, double-blind, placebo-controlled clinical trial to...
Status
Not Yet Recruiting
Location
Fundación CIDEA
Start Date
2023-11-01
Trial ID
NCT05641272
Treatments Being Tested
The present study will investigate the long term effect of allergen immunot...
Status
Recruiting
Location
Hans Christian Andersen Children's Hospital
Start Date
2024-05-01
Trial ID
NCT06421415
Treatments Being Tested
The main purpose of this trial is to investigate if any of three different ...
Status
Completed
Location
Cetero Research
Start Date
2009-09
Trial ID
NCT00987909
The purpose of this 2-year study is to assess the sustained clinical effica...
Status
Completed
Location
Alergologicka ordinace
Start Date
2010-11
Trial ID
NCT01731249
Treatments Being Tested
This study is designed to give additional information on the efficacy, safe...
Status
Completed
Location
MHAT PLovdiv, ENT Clinic
Start Date
2007-08
Trial ID
NCT00824447
Specific immunotherapy with recombinant birch pollen allergen rBet v1-FV...
Status
Completed
Location
Allergopharma GmbH & Co. KG
Start Date
2003-07
Trial ID
NCT00266526
Treatments Being Tested
To expand knowledge on the application and tolerability of immunotherapy wi...
Status
Completed
Location
Multiple Locations
Start Date
2015-12-01
Trial ID
NCT02609581
Treatments Being Tested
The trial is performed to assess efficacy and safety of Novo-Helisen Depot ...
Status
Completed
Location
Allergopharma GmbH & Co. KG
Start Date
2002-09
Trial ID
NCT00263549
Treatments Being Tested